Pharmafile Logo
Pharmafocus logo
Advanced Search

FDA grants accelerated approval for Janssen’s lung cancer drug

May 24, 2021
Sales and Marketing

The FDA have granted accelerated approval of Rybrevant (amivantamab-vmjw) for the treatment of patients with metastatic non-small cell lung cancer …

News

Vaccines highly effective against Indian variant, study shows

May 24, 2021
Sales and Marketing

A new Public Health England (PHE) study shows that two doses of either the Pfizer-BioNTech or the Oxford-AstraZeneca vaccine are …

News

BMS follow-up data sees long-term survival for melanoma patients

May 24, 2021
Sales and Marketing BMS, skin cancer

Bristol Myers Squibb (BMS) has announced follow-up data from their Phase III CheckMate-067 clinical trial, which demonstrated that 49% of …

News
janssen_latest_logo_on_sign_closer

NICE rejects Janssen’s prostate cancer drug Erleada

May 21, 2021
Medical Communications

NICE has published has published draft guidance rejecting Janssen’s Erleada (apalutamide) with androgen deprivation therapy (ADT) for treating prostate cancer. …

News

Australian PM calls for domestic mRNA vaccine production

May 21, 2021
Medical Communications Australia, Moderna, Vaccine, mrna

Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing of mRNA vaccines, to strengthen …

News
international-2693231_1920

Japan approves Moderna & AstraZeneca COVID-19 vaccines

May 21, 2021
Medical Communications COVID-19, Japan, Vaccine

A Japanese government panel has approved Moderna and AstraZeneca’s COVID-19 vaccines for use in adults, bringing the total number of …

News

Dogs can detect COVID-19 with 97% accuracy, study finds

May 21, 2021
Medical Communications

A French trial has found has found that dogs are able to detect COVID-19 with 97% accuracy in humans, which …

News
top_10_image_2_9

Pharmafile.com’s top 10 news stories of the week

May 21, 2021
Medical Communications

Among our ten most-read stories this week: Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows, while a …

News
pfizer_building_logo2_1

EU signs contract for 1.8bn more Pfizer vaccines

May 20, 2021

The European Commission has signed a deal with Pfizer-BioNTech to purchase an additional 1.8 billion doses of its COVID-19 vaccine …

News

FDA clears IND application for GammaDelta’s cancer therapy treatment

May 20, 2021

GammaDelta has received FDA clearance of its Investigational New Drug (IND) application for GDX012, a novel allogeneic variable delta 1 …

News
vertex-headquarters

Vertex applies to expand indication of cystic fibrosis drug

May 20, 2021
EMA, MHRA, cystic fibrosis

Vertex has announced that the EMA and MHRA have validated the post marketing applications for an expanded indication of Kaftiro …

News

New treatment available to patients with rare blood disorders

May 20, 2021

Hundreds of people with rare blood disorders will have access to a new treatment following guidance from NICE today. The …

News

World’s first COVID-19 vaccine booster study launches in UK

May 20, 2021
COVID-19, UK government, booster vaccine, clinical trial, vaccines

The UK government has announced that thousands of volunteers will receive a booster COVID-19 vaccine in a new clinical trial, …

News
covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

May 19, 2021
Research and Development

The past week has seen lots of positive COVID-19 vaccine news; the Pfizer-BioNTech vaccine can be refrigerated much longer than …

News

‘Black fungus’ drug in short supply across India

May 19, 2021
Research and Development

Amphotericin B, an anti-fungal drug used to treat the rare infection mucormycosis, or ‘black fungus’, is in short supply across …

News

UK medical cannabis study finds anxiety, pain, and sleep improvements

May 19, 2021
Research and Development

The first ever UK medical cannabis study has found significant improvements in anxiety, pain, and sleep in patients following treatment …

News

Exscientia and BMS announce $1.2 billion collaboration

May 19, 2021
Research and Development AI

Artificial intelligence (AI) pharmatech company, Exscientia, has announced a collaboration with Bristol Myers Squibb to accelerate the discovery of small …

News

BD unveils plan for €165 million Spanish manufacturing plant

May 19, 2021
Research and Development EU, manufacturing

BD has announced plans to build a new €160 million manufacturing plant in Zaragoza, located in the Aragon region of …

News

AI software assists in radiographic fracture detection

May 18, 2021
Manufacturing and Production

GLEAMER’s BoneView, an artificial intelligence system, when combined with health professionals’ interpretations, lowered the false negative rate (undetected fractures) on …

News

Sandoz announces €150 million investment in antibiotic production

May 18, 2021
Manufacturing and Production EU, manufacturing, production

Sandoz, a division of Novartis, has announced plans to develop its European antibiotics manufacturing network by expanding the production capabilities …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026